{"id":9579,"date":"2026-05-21T17:10:00","date_gmt":"2026-05-21T15:10:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=aa93454efc91d88bbd218ebdca4fa390"},"modified":"2026-05-21T17:10:00","modified_gmt":"2026-05-21T15:10:00","slug":"biovigil-appoints-brad-ryba-as-chief-technology-officer-to-accelerate-innovation-and-market-expansion","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=9579","title":{"rendered":"BioVigil Appoints Brad Ryba as Chief Technology Officer to Accelerate Innovation and Market Expansion"},"content":{"rendered":"

ANN ARBOR, Mich.--(BUSINESS WIRE)--BioVigil, the market leader in electronic hand hygiene and infection prevention technology, has hired Brad Ryba as the company\u2019s Chief Technology Officer (CTO). Ryba will lead the company\u2019s technology and data strategy, driving greater interoperability and integration across the BioVigil platform, while advancing its mission to improve safety and accountability in healthcare.<\/p><\/a><\/a><\/a><\/a>

\nBioVigil is the only automated solution that provides individual hand hygiene verification and real-time compliance correction. The smart badge uses a patented alcohol vapor-sensor that confirms when sanitizer is used on hands \u2013 the only such wearable available in market today. Data is linked to each user\u2019s badge, so teams can monitor hand hygiene compliance, track cross contamination, and conduct thorough contact-tracing.<\/p>

\n\u201cWith the healthcare market rapidly evolving, smart hospitals of the future are demanding intelligent, integrated solutions that enhance clinical workflows and elevate patient safety,\u201d said Erik Axter, CEO of BioVigil. \u201cBrad\u2019s deep experience in device design and data scale expertise is an ideal fit for our mission. His expertise will enhance BioVigil\u2019s ability to blend seamlessly into existing workflows and provide unique clinical and operational value.\u201d<\/p>

\nRyba brings more than 25 years of technology leadership spanning SaaS, healthcare technology, insurance, telecommunications, and e\u2011commerce. He has consistently driven software quality, process redesign, and cross\u2011functional execution. A respected technology executive, Ryba has partnered with Fortune 500 organizations to implement strategic technology initiatives and build robust data platforms.<\/p>

\n\u201cI\u2019m thrilled to join BioVigil at such a pivotal moment in patient and caregiver safety,\u201d said Ryba. \u201cI\u2019m excited to help scale our technology, data strategy, and platform capabilities in ways that help healthcare organizations improve safety, accountability, quality and outcomes.\u201d<\/p>

\nBioVigil is trusted by hospitals nationwide, ranging from large multi-state health systems to community hospitals, to automate hand hygiene excellence. BioVigil partners have an average real compliance rate of 94% and an average HAI reduction rate of 46%.<\/p>

\nAbout BioVigil<\/b><\/p>

\nFounded in 2012, BioVigil is the leader in hand hygiene automation, using proprietary vapor-sensing technology to confirm and verify that hand hygiene occurred. BioVigil delivers over 100 observations per bed per day and captures accurate, meaningful data for a true view of compliance. Real-time visual, audible, and vibratory cues support immediate course correction, while a visible green-hand indicator builds patient trust. Healthcare systems use BioVigil technology to deliver safer care and reduce HAIs without disrupting workflow or requiring IT infrastructure. Learn more at BioVigil.com.<\/a><\/p> Contacts<\/b>

\nMedia Contact:<\/b>Debbie Reinheimer, debbie@reinheimerpr.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

ANN ARBOR, Mich.–(BUSINESS WIRE)–BioVigil, the market leader in electronic hand hygiene and infection prevention technology, has hired Brad Ryba as the company\u2019s Chief Technology Officer (CTO). Ryba will lead the company\u2019s technology and data strateg…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9579","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9579"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9579\/revisions"}],"predecessor-version":[{"id":9580,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9579\/revisions\/9580"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}